Cargando…
Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
Autores principales: | Maillet-Lebel, Nicole, Thibeault, Marie-Marthe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992004/ https://www.ncbi.nlm.nih.gov/pubmed/27570817 http://dx.doi.org/10.1016/j.jdcr.2016.07.006 |
Ejemplares similares
-
Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
por: Menzer, Christian, et al.
Publicado: (2022) -
PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
por: Callejas Charavia, M., et al.
Publicado: (2022) -
Nodular cutaneous amyloidosis effectively treated with intralesional methotrexate
por: Raymond, James, et al.
Publicado: (2016) -
New World Cutaneous Leishmaniasis Treated with Intralesional Injection of Pentavalent Antimony
por: Shin, Ji Yeon, et al.
Publicado: (2013) -
Cutaneous granulomatous reaction as the first manifestation of Hodgkin's lymphoma
por: Moreira, Catarina, et al.
Publicado: (2017)